Neurogene (NGNE) executive Cobb received 7,200 shares

Insider transactions reported

Stuart Cobb (Chief Scientific Officer at Neurogene Inc., NGNE) reported that they received 7,200 shares on Mar 26, 2025. After these transactions the filing shows 27,591 shares held directly.

Reporting person

Cobb Stuart

Role

Chief Scientific Officer

Options and other derivatives

Holdings before and after

• Common Stock: 20,391 to 27,591 direct
• Employee Stock Option (Right to buy): 0 to 42,900 direct

Footnotes from the filing

1. 1. Consists of 7,200 restricted stock units, which will vest in three equal annual installments beginning with the first anniversary of the grant date, subject to the Reporting Person's continued provision of services to the Issuer on each vesting date.
2. 2. This option represents the right to purchase 42,900 shares of the Issuer's common stock, one quarter of which will vest on the first anniversary of the grant date with the remaining three quarters vesting in equal month installments through the fourth anniversary of the grant date.

Transaction codes in this filing

Grant or award:

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ